Clinical Trial

ALPs Single ChambEr New Device Study

Name: ALPs Single ChambEr New Device Study — clinical trial record (NCT07469579)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ASCEND

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Prospective, non-randomized, multi-center, international study designed to evaluate the initial safety and performance of the ALPS leadless pacemaker when used in patients with bradycardia.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-09.

Trial Details

NCT Number	NCT07469579
Lead Sponsor	Cairdac SA
Conditions	Brady-tachy Syndrome, Brady Arrythmia, Bradycardia, AV Block, Atrial Fibrillation (Paroxysmal)
Enrollment	15 participants
Start Date	2026-06
Primary Completion	2027-03 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-03-18